IBDEI1LU ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27226,1,3,0)
 ;;=3^93224
 ;;^UTILITY(U,$J,358.3,27227,0)
 ;;=93225^^105^1341^4^^^^1
 ;;^UTILITY(U,$J,358.3,27227,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27227,1,2,0)
 ;;=2^ECG Monitor < 48hrs,Recording Only
 ;;^UTILITY(U,$J,358.3,27227,1,3,0)
 ;;=3^93225
 ;;^UTILITY(U,$J,358.3,27228,0)
 ;;=93226^^105^1341^1^^^^1
 ;;^UTILITY(U,$J,358.3,27228,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27228,1,2,0)
 ;;=2^ECG Monitor < 48hrs,Analysis & Rpt
 ;;^UTILITY(U,$J,358.3,27228,1,3,0)
 ;;=3^93226
 ;;^UTILITY(U,$J,358.3,27229,0)
 ;;=93227^^105^1341^2^^^^1
 ;;^UTILITY(U,$J,358.3,27229,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27229,1,2,0)
 ;;=2^ECG Monitor < 48hrs,Intrp
 ;;^UTILITY(U,$J,358.3,27229,1,3,0)
 ;;=3^93227
 ;;^UTILITY(U,$J,358.3,27230,0)
 ;;=36245^^105^1342^1^^^^1
 ;;^UTILITY(U,$J,358.3,27230,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27230,1,2,0)
 ;;=2^Ins Cath Abd/L-Ext Art,1st
 ;;^UTILITY(U,$J,358.3,27230,1,3,0)
 ;;=3^36245
 ;;^UTILITY(U,$J,358.3,27231,0)
 ;;=96523^^105^1342^2^^^^1
 ;;^UTILITY(U,$J,358.3,27231,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27231,1,2,0)
 ;;=2^Irrig Drug Delivery Device
 ;;^UTILITY(U,$J,358.3,27231,1,3,0)
 ;;=3^96523
 ;;^UTILITY(U,$J,358.3,27232,0)
 ;;=Z49.31^^106^1343^1
 ;;^UTILITY(U,$J,358.3,27232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27232,1,3,0)
 ;;=3^Adequacy Testing for Hemodialysis
 ;;^UTILITY(U,$J,358.3,27232,1,4,0)
 ;;=4^Z49.31
 ;;^UTILITY(U,$J,358.3,27232,2)
 ;;=^5063058
 ;;^UTILITY(U,$J,358.3,27233,0)
 ;;=N18.6^^106^1343^3
 ;;^UTILITY(U,$J,358.3,27233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27233,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,27233,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,27233,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,27234,0)
 ;;=Z99.2^^106^1343^2
 ;;^UTILITY(U,$J,358.3,27234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27234,1,3,0)
 ;;=3^Dependence on Renal Dialysis
 ;;^UTILITY(U,$J,358.3,27234,1,4,0)
 ;;=4^Z99.2
 ;;^UTILITY(U,$J,358.3,27234,2)
 ;;=^5063758
 ;;^UTILITY(U,$J,358.3,27235,0)
 ;;=Z91.15^^106^1343^4
 ;;^UTILITY(U,$J,358.3,27235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27235,1,3,0)
 ;;=3^Patient's Noncompliance w/ Renal Dialysis
 ;;^UTILITY(U,$J,358.3,27235,1,4,0)
 ;;=4^Z91.15
 ;;^UTILITY(U,$J,358.3,27235,2)
 ;;=^5063617
 ;;^UTILITY(U,$J,358.3,27236,0)
 ;;=Z49.32^^106^1344^1
 ;;^UTILITY(U,$J,358.3,27236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27236,1,3,0)
 ;;=3^Adequacy Testing for Peritoneal Dialysis
 ;;^UTILITY(U,$J,358.3,27236,1,4,0)
 ;;=4^Z49.32
 ;;^UTILITY(U,$J,358.3,27236,2)
 ;;=^5063059
 ;;^UTILITY(U,$J,358.3,27237,0)
 ;;=N18.6^^106^1344^2
 ;;^UTILITY(U,$J,358.3,27237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27237,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,27237,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,27237,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,27238,0)
 ;;=I25.10^^106^1345^3
 ;;^UTILITY(U,$J,358.3,27238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27238,1,3,0)
 ;;=3^Athscl Hrt Disease,Native Coronary Artery w/o Angina Pectoris
 ;;^UTILITY(U,$J,358.3,27238,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,27238,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,27239,0)
 ;;=I42.8^^106^1345^7
 ;;^UTILITY(U,$J,358.3,27239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27239,1,3,0)
 ;;=3^Cardiomyopathy,Other
 ;;^UTILITY(U,$J,358.3,27239,1,4,0)
 ;;=4^I42.8
 ;;^UTILITY(U,$J,358.3,27239,2)
 ;;=^5007199
 ;;^UTILITY(U,$J,358.3,27240,0)
 ;;=I48.91^^106^1345^4
 ;;^UTILITY(U,$J,358.3,27240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27240,1,3,0)
 ;;=3^Atrial Fibrillation,Unspec
 ;;^UTILITY(U,$J,358.3,27240,1,4,0)
 ;;=4^I48.91
